The latest from HNF: research updates, patient stories, advocacy wins, events, and CMT community news.
No matches for .
Showing 49 to 60 of 316
January 13, 2025
Early preclinical research indicates that ALE2 could effectively slow or halt the progression of these debilitating symptoms, offering new hope for patients with these rare forms of CMT.
January 10, 2025
Experience the 2025 HNF CMT Summit & Wellness Retreat in Nashville, TN, April 24-26!
January 7, 2025
January 7, 2025
NMD670, has been granted Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA)
November 26, 2024
November 19, 2024
October 3, 2024
Event Details: San Antonio, TX: December 7-8, 2024 (5K, 10K, Half Marathon, Full Marathon)
September 23, 2024
September 18, 2024
Join the thousands of HNF volunteers who are fueling CMT research. The more you share, the more we'll learn. Complete your GRIN surveys today!
Changes how this site looks for you, and are saved on this device.
We use cookies to see how the site is used (analytics) and to power embedded videos and podcasts. Analytics stay off until you say yes. See our privacy policy.
Be the first to know
Research moves fast. Add your number and we will text you the things that matter most: new treatment news, trial openings, and ways to take part before they fill up.
